Search results
Results from the WOW.Com Content Network
An assortment of Lilly's throat lozenges from a 1906 sales book Josiah K. Lilly Sr. (1861–1948), the company's second president Eli Lilly and Company's corporate headquarters in Indianapolis, c. 1919 Men and women workers preparing drug capsules at Eli Lilly and Company in 1919 Amaryllis belladonna cultivation at Eli Lilly and Company in 1919 ...
Pharmaceutical giant Eli Lilly (NYSE: LLY) is having a moment right now. Over the last two years the company has made a splash in the weight loss space thanks to its one-two punch of blockbuster ...
Eli Lilly (NYSE: LLY) soared more than 60% from the start of the year through its peak this summer, thanks to the company's dominance in one of today's most in-demand areas: the obesity drug market.
Eli Lilly And Co (NYSE: LLY) announced Tuesday a big-ticket acquisition that would mark its foray into gene therapy research.What Happened: Lilly said it has agreed to buy gene therapy company ...
While Danish-based pharmaceutical company Novo Nordisk (NYSE: NVO) leads the GLP-1 market (thanks in large part to enthusiasm for its pioneering Ozempic drug), its chief rival Eli Lilly (NYSE: LLY ...
For Eli Lilly CEO Dave Ricks, speeding up the drug discovery process is essential to success. ... And I think we often have lost our way as an industry or even as a company when we don't pay ...
Eli Lilly (NYSE: LLY) stock has climbed in the double digits over the past year thanks to its leading position in one of the highest-growth pharmaceutical markets around: weight loss drugs. Lilly ...
Powered by its popular GLP-1 weight loss drugs, Eli Lilly's stock (NYSE: LLY) has had a strong run this year, up more than 55%. However, the company's success goes back much further, with the ...